FGF-trapping hampers cancer stem-like cells in uveal melanoma
Cancer Cell International,
Abstract Background Cancer stem-like cells (CSCs) are a subpopulation of tumor cells responsible for tumor initiation…
Abstract Background Cancer stem-like cells (CSCs) are a subpopulation of tumor cells responsible for tumor initiation…
Ocular melanoma and uveal melanoma are essentially the same. When ocular melanoma begins in the uvea, it is called uveal…
March 23, 2021 Medically Reviewed by iStock March 23, 2021 Medically Reviewed by Melanoma is usually associated with the skin…
Data Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting II Show Synergism between FAK and RAF…
The combination of VS-6766 and the focal adhesion kinase (FAK) inhibitor defactinib is currently being investigated in an…
| Spoke Verastem Oncology Announces Presentation of Preclinical Data Supporting the Combination of VS-6766 and Defactinib in…
Data Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting II Show Synergism between FAK and RAF…
BOSTON--(Business Wire)--Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed…
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and…
- Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and…
Data Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting II Show Synergism between FAK and RAF…
Data Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting II Show Synergism between FAK and RAF…
Data Presented at the American Association for Cancer Research 2020 Virtual Annual Meeting II Show Synergism between FAK and RAF…
BOSTON--( BUSINESS WIRE )-- Verastem Oncology, Inc. (Nasdaq:VSTM) a biopharmaceutical company committed to developing and…